IPO registrations (S-1, F-1) · Registrants

Manuka, Inc.

SEC CIK
1062128 · filings on EDGAR ↗
Name on the registration
Artemis Therapeutics, Inc.
Former names
Artemis Therapeutics, Inc. (2016–2023); NEW YORK GLOBAL INNOVATIONS INC. (2013–2016); INKSURE TECHNOLOGIES INC. (2005–2014); INKSURE TECHNOLOGIES INC (2003–2005); LIL MARC INC (1998–2002)
Registration
Form S-1, first filed 2022-09-21, last 2023-01-04; 1 initial registration, 3 amendments
Outcome
Declared effective 2023-01-04
Industry (SIC)
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics 2840
Incorporated in
DE
Business address
3 ELIEZER VARDINON ST., Petach Tikva, L3 4959507
EIN
84-1417774
EDGAR entity type
operating
Insiders and CEO pay
Manuka, Inc. on the corporate pages

Offering terms

Shares offered
15,232,243 (all by selling holders)
Listing
OTC under the symbol ATMS

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
2022-09-21S-1S-1 (registration)Artemis Therapeutics, Inc.0001178913-22-003487 ↗
2022-11-21S-1/AS-1/A (amendment)Artemis Therapeutics, Inc.0001178913-22-004114 ↗
2022-12-20S-1/AS-1/A (amendment)Artemis Therapeutics, Inc.0001178913-22-004383 ↗
2023-01-04S-1/AS-1/A (amendment)Artemis Therapeutics, Inc.0001178913-23-000043 ↗
2023-01-04EFFECTEFFECT (declared effective)Artemis Therapeutics, Inc.9999999995-23-000030 ↗
2023-05-26EFFECTEFFECT (declared effective)Manuka, Inc.9999999995-23-001546 ↗

Prospectus pages read 1

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2023-01-04S-1/Aregistration statement$1.3015,232,243$19,801,915OTC ATMS0primary document; price line, shares headline, proceeds computeddocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
SASS DAVID WDirector; Director,OfficerSecretary82006–2011
ACKS MICHAELDirector22006
ATTIAS ALBERTDirector42006–2008
BIGON EYALOfficerChief Financial Officer22006
GETTER PHILIPDirector52006–2008
HOUSMAN ELIEDirector; Director,OfficerCEO & Chairman; Chairman and CEO; Chief Executive Officer72006–2008
LINEBERGER JAMES EDirector62006
MEERFELD YARONDirector; Director,OfficerActing Chief Executive Officer; Chief Operating Officer72006–2010
L & Co., LLCOther; TenPercentOwner52006
Schoenheimer Pierre LucienDirector112006–2011
BRANDT MICKEYOfficerVP and CFO12006
Rock Randy FDirector72007–2010
ICTS INTERNATIONAL N VTenPercentOwner12007
SEIDMAN SAMUEL NDirector42007–2008
PEKER TZLILOfficerChief Financial Officer; Vice President and CFO; VP & CFO42008–2010
Peleg GadiDirector; Director,OfficerChairman of the Board; Chairman ot the Board62008–2018
Raich AlonDirector52009–2011
Gilat TalOfficerPresident and CEO22010–2012
Bettsak JonathanDirector22010–2011
Avner DavidOfficerChief Financial Officer; CHIEF FINANCIAL OFFICER22010
Goldovsky ViktorOfficerVP Sales and Buisness Dev22012
Assis TomerOfficerChief Financial Officer12013
Arias Roberto Alonso JimenezDirector12014
Morris ChananOfficerChief Financial Officer22014–2018
Alfassi IsraelDirector12016
Tonak Ltd.TenPercentOwner22016–2017
Wolf DanaOfficerChief Scientific Officer22016–2017
PAYNE PETER N.OfficerChief Executive Officer12017
Culley Brian MOfficerChief Executive Officer42017–2018
CITRON SHIMONDirector,OfficerChief Executive Officer12022
Dana DavidOfficerChief Financial Officer12022

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2016-09-07NEW YORK GLOBAL INNOVATIONS INC.Biotechnology$500,000$500,00011

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerNEW YORK GLOBAL INNOVATIONS INC.NYForm D private offeringsCIK (EXACT)
SEC filerArtemis Therapeutics, Inc.SEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics, L3 first:

More with this interest.

In other datasets, the same topic (Health) in L3:

Interests: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · Health